GlassScriptPhysician profile
Michelle E Newton
NPI 1518505684
$2,868.83
in general payments reported to CMS, 2019-2025
12 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $200 · 2023: $172 · 2024: $1,924 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450 · Travel and Lodging: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.96 |
| Travel and Lodging | $937.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,561.72 | 2022-2024 | |
| Organogenesis INC. | $280.21 | 2021-2025 | Apligraf, Affinity, Puraply Am |
| Smith+Nephew, INC. | $255.45 | 2021-2025 | Collagenase Santyl, Renasys Touch, Regranex |
| Abbvie INC. | $234.34 | 2021-2024 | |
| Mimedx Group, INC. | $212.07 | 2024-2025 | |
| Melinta Therapeutics, LLC | $119.62 | 2021-2023 | Kimyrsa |
| Hartmann USA, INC. | $63.56 | 2021-2025 | Zetuvit Plus 10x10 P10 |
| Kerecis Limited | $45.65 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Janssen Pharmaceuticals, INC | $32.56 | 2021-2022 | |
| Bsn Medical INC | $28.46 | 2024 | |
| Averitas Pharma INC. | $20.92 | 2025 | Qutenza |
| Misonix INC | $14.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Newton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.